Moderna CEO says at-risk patients ‘undoubtedly’ last vaccinated need boosters
Food and Drug Administration Modern’s COVID-19 . leaning toward approving half the dose of Vaccination According to a report as a booster shot.
The agency is satisfied that the dosage level will provide adequate protection against the virus, people familiar with the matter told Bloomberg News.
Modern CEO says COVID-19 pandemic could be over in a year
Moderna had pushed for a half-dose shot in its booster application submitted to federal regulators on September 1.
Each shot in the drug manufacturer’s original vaccine contains 100 micrograms of mRNA.
In comparison, Pfizer has 30 micrograms in both the starting and booster doses, the report said.
FDA Pfizer’s booster is approved For people over the age of 65, and those who are older than 18 and who have an underlying medical condition that makes them more vulnerable to illness, or are at higher risk of getting the virus from their work – such as health care workers and teachers.
Centers for Disease Control and Prevention currently recommends that people get their boosters from the same drug manufacturer as their original dose.